When was SynchNeuro founded?

SynchNeuro was founded in 2021 and raised its 1st funding round 4 years after it was founded.

Where is SynchNeuro located?

SynchNeuro is headquartered in Philadelphia, United States.

How many employees does SynchNeuro have?

As of Aug 31, 2026, the latest employee count at SynchNeuro is 9.

Is SynchNeuro a funded company?

SynchNeuro is a funded company, having raised a total of $***** in its 1st and only funding round, a Seed round on Nov 12, 2025.

When was the latest funding round of SynchNeuro?

SynchNeuro's latest funding was a $***** Seed round on Nov 12, 2025, with participation from 1 investor.

Where does SynchNeuro rank among its competitors?

SynchNeuro ranks 57th amongst 100 active competitors, of which 28 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Wellumio, which secured $9.75M in Jul, 2026.

Who are the top competitors of SynchNeuro?

SynchNeuro's top competitors include Neuralink, BrainScope and NeuroOne. Among them, Wellumio secured the most recent funding round in July, 2026.

SynchNeuro - 2026 Company Profile, Team, Funding & Competitors

Company Details

Developer of tools for brain-metabolic health research and product development. The organization provides opportunities to participate in research studies and receive updates on product launches and educational content. It gathers data related to age, gender, and other demographic information for research purposes. Participation in research is voluntary and subject to a separate informed consent process.

Key Metrics

Founded Year

2021

Location

Philadelphia, United States

Stage

Seed

Latest Funding Round

Seed, Nov 12, 2025, $*****

Investors

Boomerang Ventures

Ranked

57^th among 100 active competitors

Employee Count

9 as on Aug 31, 2026

Similar Companies

Neuralink & 116 more

View SynchNeuro's full profile

SynchNeuro has raised funding over 1 round. Its latest funding round was a Seed round on Nov 12, 2025 for $*****. 1 investor participated in its latest round. SynchNeuro has 1 institutional investor.

Here is the list of recent funding rounds of SynchNeuro:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Nov 12, 2025	3706678	Seed	6364683	6751911	9836227	5191262

Access funding benchmarks and valuations. Sign up today!

View details of SynchNeuro's funding rounds and investors

The founders of SynchNeuro are Casey Halpern and Emily M.

Here are the details of SynchNeuro's key team members:

Casey Halpern: Co-Founder & Chairman of SynchNeuro.
Contact Info: 1 email address
Emily M: President & Co-Founder of SynchNeuro.

View details of SynchNeuro's Founder profiles and Board Members

SynchNeuro's employee count trend

SynchNeuro has 9 employees as of Aug 26. Here is SynchNeuro's employee count trend over the years:

Uncover SynchNeuro's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of SynchNeuro include Neuralink, BrainScope and NeuroOne. Here is the list of Top 10 competitors of SynchNeuro, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Neuralink 2016, Fremont (United States), Series E	Provider of implantable brain-computer interfaces	$1.29B	Founders Fund, Vy Capital & 37 others	66/100
2nd	BrainScope 2006, Bethesda (United States), Series B	Provider of AI-powered non-invasive medical devices for diagnosing and assessing brain injuries, including concussions and brain bleeds	$62.2M	Maryland Venture Fund, Aon & 11 others	58/100
3rd	NeuroOne 2023, Eden Prairie (United States), Public	Developer of minimally invasive thin film electrodes for the diagnosis of neurological conditions	-	-	55/100
4th	Wellumio 2019, Wellington (New Zealand), Seed	Provider of MRI-based device for the diagnosis of stroke	$14.9M	Nuance, Flying Kiwi Angels & 9 others	53/100
5th	Kernel 2016, Los Angeles (United States), Series C	Developer of multimodal brain measurement technology for neuromedicine	$158M	General Catalyst, Eldridge Industries & 3 others	51/100
6th	Compumedics 1987, Melbourne (Australia), Public	Manufacturer of diagnostic and monitoring devices for sleep and neurological disorders	-	Herald Investment Management	49/100
7th	Rhythmlink 2002, Columbia (United States), Acquired	Provider of brain health medical devices	-	Graham Partners, Stellus Capital Management ... & 1 others	43/100
8th	ANT Neuro 1997, Enschede (Netherlands), Unfunded	Digital neurodiagnostic solution for providers	-	-	42/100
9th	DiagnaMed 2020, Toronto (Canada), Public	AI-based digital diagnostics and therapeutics solutions for brain health	-	-	41/100
10th	NIRSense 2019, Richmond (United States), Funding Raised	Developer of a platform for neurovascular conditions	-	Lighthouse Labs	40/100
57th	SynchNeuro 2021, Philadelphia (United States), Seed	Developer of tools for brain-metabolic health research and product development	-	Boomerang Ventures	27/100